CIGB-300 internalizes and impairs viability of NSCLC cells lacking actionable targets by inhibiting casein kinase-2 signaling
Ying Yi(Huaihua University), Yasser Perera(Construction Development (Qatar))
Cited by 5
Related Papers
Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway
|Experimental and Therapeutic Medicine|2017|32
Urea transporter <scp>UT</scp> ‐ <scp>A1</scp> as a novel drug target for hyponatremia
|The FASEB Journal|2024|8